Cite Filings / ORIC / 0001193125-22-310169

Feed Companies Filings Check

Sign in

8-K

Current Report

Oric Pharmaceuticals, Inc. Filed 2022-12-21 Acc 0001193125-22-310169

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , d399008d8k.htm

Around this filing

2023-01-09 8-K Results of operations · Regulation FD disclosure
2022-12-21 8-K Other events
2022-12-21 424B5 Prospectus
2022-12-16 4 Chief Medical Officer sold 2,089 shares at $3.25 ($6,789)
2022-12-16 4 Chief Financial Officer sold 2,089 shares at $3.25 ($6,789)
2022-12-16 4 President and CEO sold 5,764 shares at $3.25 ($18,733)
2022-11-07 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading d399008d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…